{"entity":{"type":"insider","cik":"0001616284","url":"/insider/0001616284","json_url":"/insider/0001616284.json","name":"Saik Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2020-09-08","last":"2026-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Saik Andrew","source":"filing","n_filings":5,"first_seen":"2020-09-08","last_seen":"2026-06-24"}],"transactions":[{"id":6059637,"accession":"0001628280-26-045286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-045286","line_url":"/filing/0001628280-26-045286#line-1","is_derivative":false,"issuer_cik":"0001616284","issuer_name":"ARVINAS, INC.","issuer_ticker":"ARVN","issuer_name_source":null,"issuer_url":"/issuer/0001616284","owner_cik":"0001616284","owner_name":"Saik Andrew","owner_url":"/insider/0001616284","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5696.0,"shares_display":"5,696","price_per_share":8.159,"price_display":"8.16","price_state":"stated","total_value":46473.664,"total_display":"46,473.66","shares_owned_after":187432.0,"shares_owned_after_display":"187,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-24","scope":"insider"},{"id":5896385,"accession":"0001628280-26-034615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-034615","line_url":"/filing/0001628280-26-034615#line-1","is_derivative":false,"issuer_cik":"0001616284","issuer_name":"ARVINAS, INC.","issuer_ticker":"ARVN","issuer_name_source":null,"issuer_url":"/issuer/0001616284","owner_cik":"0001616284","owner_name":"Saik Andrew","owner_url":"/insider/0001616284","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11139.0,"shares_display":"11,139","price_per_share":9.9374,"price_display":"9.94","price_state":"stated","total_value":110692.6986,"total_display":"110,692.70","shares_owned_after":193128.0,"shares_owned_after_display":"193,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-13","scope":"insider"},{"id":5982457,"accession":"0001628280-26-009306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-009306","line_url":"/filing/0001628280-26-009306#line-1","is_derivative":false,"issuer_cik":"0001616284","issuer_name":"ARVINAS, INC.","issuer_ticker":"ARVN","issuer_name_source":null,"issuer_url":"/issuer/0001616284","owner_cik":"0001616284","owner_name":"Saik Andrew","owner_url":"/insider/0001616284","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5134.0,"shares_display":"5,134","price_per_share":11.89,"price_display":"11.89","price_state":"stated","total_value":61043.26,"total_display":"61,043.26","shares_owned_after":159267.0,"shares_owned_after_display":"159,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-18","scope":"insider"},{"id":4890238,"accession":"0001655759-25-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001655759-25-000109","line_url":"/filing/0001655759-25-000109#line-1","is_derivative":false,"issuer_cik":"0001616284","issuer_name":"ARVINAS, INC.","issuer_ticker":"ARVN","issuer_name_source":null,"issuer_url":"/issuer/0001616284","owner_cik":"0001616284","owner_name":"Saik Andrew","owner_url":"/insider/0001616284","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":7.61,"price_display":"7.61","price_state":"stated","total_value":43377.0,"total_display":"43,377.00","shares_owned_after":164401.0,"shares_owned_after_display":"164,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-24","scope":"insider"},{"id":3323652,"accession":"0001209191-20-049796","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-049796","line_url":"/filing/0001209191-20-049796#line-1","is_derivative":false,"issuer_cik":"0001566044","issuer_name":"VYNE Therapeutics Inc.","issuer_ticker":"VYNE","issuer_name_source":null,"issuer_url":"/issuer/0001566044","owner_cik":"0001616284","owner_name":"Saik Andrew","owner_url":"/insider/0001616284","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":1.462,"price_display":"1.46","price_state":"stated","total_value":58480.0,"total_display":"58,480.00","shares_owned_after":340000.0,"shares_owned_after_display":"340,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001655759","name":"ARVINAS, INC.","url":"/issuer/0001655759","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2025-06-24","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001566044","name":"VYNE Therapeutics Inc.","url":"/issuer/0001566044","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2020-09-08","last_seen":"2020-09-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001616284","retrieved_at":"2026-08-21T20:34:25+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}